{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T14:51:25Z","timestamp":1791903085778,"version":"4.3.4"},"reference-count":80,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2008,12,30]],"date-time":"2008-12-30T00:00:00Z","timestamp":1230595200000},"content-version":"vor","delay-in-days":4381,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Anaesthesiol Scand"],"published-print":{"date-parts":[[1997,1]]},"abstract":"<jats:p>Morphine is a potent opioid analgesic widely used for the treatment of acute pain and for long\u2010term treatment of severe pain. Morphine is a member of the morphinan\u2010framed alkaloids, which are present in the poppy plant. The drug is soluble in water, but its solubility in lipids is poor.<\/jats:p><jats:p>In man, morphine\u20103\u2010glucuronide (M3G) and morphine\u20106\u2010glucu\u2010ronide (M6G) are the major metabolites of morphine. The metabolism of morphine occurs not only in the liver, but may also take place in the brain and the kidneys. The glucuronides are mainly eliminated via bile and urine. Glucuronides as a rule are considered as highly polar metabolites unable to cross the blood\u2010brain barrier. Although morphine glucuronidation has been demonstrated in human brain tissue, the capacity is very low compared to that of the liver, indicating that the M3G and M6G concentrations observed in the cerebrospinal fluid (CSF) after systemic administration reflect hepatic metabolism of morphine and that the morphine glucuronides, despite their high polarity, can penetrate into the brain. Like morphine, M6G has been shown to be relatively more selective for \u03bc\u2010receptors than for 5\u2010 and K\u2010receptors while M3G does not appear to compete for opioid receptor binding.<\/jats:p><jats:p>The analgesic properties of M6G were recognised in the early 1970s and more recent work suggests that M6G might significantly contribute to the opioid analgesia after administration of morphine. The analgesic potency of M6G after intracerebroven\u2010tricular (ICV) or intrathecal (IT) administration in rats is from 45\u2013800 timer greater than that of morphine, depending on the animal species and the experimental antinociceptive test used. Furthermore, the development of a sensitive high\u2010performance liquid chromatography (HPLC) assay for the quantitative determination of morphine, M6G and M3G has revealed that M6G and M3G were present in abundance after chronic oral morphine administration and that the area under the plasma concentration\u2010time curve exceeded that of morphine. M3G has been found to antagonise morphine and M6G induced analgesia and ventilatory depression in the rat, which has led to the hypothesis that M3G may influence the development of morphine tolerance. M3G exhibits no analgesic effect after ICV or IT administration. Some studies do, however, indicate that M3G may cause non\u2010opioid mediated hyperalgesia\/allodynia and convulsions after IT administration in rats. These observations led to the hypothesis that M3G might be responsible for side\u2010effects, hyperalgesia\/allodynia and myoclonus seen after high\u2010dose morphine treatment.<\/jats:p>","DOI":"10.1111\/j.1399-6576.1997.tb04625.x","type":"journal-article","created":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T04:41:46Z","timestamp":1230784906000},"page":"116-122","source":"Crossref","is-referenced-by-count":240,"title":["Morphine metabolites"],"prefix":"10.1111","volume":"41","author":[{"given":"L. L.","family":"CHRISTRUP","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,12,30]]},"reference":[{"key":"e_1_2_1_2_2","first-page":"47","article-title":"Darstellung der reinen Mohnsaure (Opiumsaure) nebst einer chemischen Untersuchung des Opiums mit vorziiglicher Hinsicht auf einen darin neuen Stoff und die dahin gehbringen Bemerkungen","volume":"14","author":"Sertiirner FW.","year":"1806","journal-title":"Trommdorfs J Pharm"},{"key":"e_1_2_1_3_2","doi-asserted-by":"publisher","DOI":"10.1039\/ct9232300980"},{"key":"e_1_2_1_4_2","first-page":"903","article-title":"The morphine group. Part III. The constitution of neopine","volume":"1926","author":"Duin CF","year":"1923","journal-title":"J Chem Soc"},{"key":"e_1_2_1_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/jlac.19274520114"},{"key":"e_1_2_1_6_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja01124a538"},{"key":"e_1_2_1_7_2","doi-asserted-by":"publisher","DOI":"10.1021\/ja01588a033"},{"key":"e_1_2_1_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90039-E"},{"key":"e_1_2_1_9_2","first-page":"988","volume-title":"The Merck Index","author":"Budavari S.","year":"1989"},{"key":"e_1_2_1_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510130607"},{"key":"e_1_2_1_11_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1981.214"},{"key":"e_1_2_1_12_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1985.tb02675.x"},{"key":"e_1_2_1_13_2","doi-asserted-by":"publisher","DOI":"10.1038\/clpt.1990.2"},{"key":"e_1_2_1_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/cpt1974161part151"},{"key":"e_1_2_1_15_2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0022-3565(25)30046-7","article-title":"Urinary excretion of morphine and its metabolites in morphine\u2013dependent subjects","volume":"192","author":"Yeh SY.","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_16_2","doi-asserted-by":"publisher","DOI":"10.3109\/03602537508993748"},{"key":"e_1_2_1_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/63.4.380"},{"key":"e_1_2_1_18_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1988.tb00965.x"},{"key":"e_1_2_1_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(88)90219-9"},{"key":"e_1_2_1_20_2","doi-asserted-by":"publisher","DOI":"10.1248\/cpb.18.2414"},{"key":"e_1_2_1_21_2","doi-asserted-by":"publisher","DOI":"10.1002\/jps.2600660921"},{"key":"e_1_2_1_22_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.363"},{"key":"e_1_2_1_23_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(91)90150-A"},{"key":"e_1_2_1_24_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(89)91184-0"},{"key":"e_1_2_1_25_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.105.45"},{"key":"e_1_2_1_26_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0378-4347(00)80494-6"},{"key":"e_1_2_1_27_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb02880.x"},{"key":"e_1_2_1_28_2","doi-asserted-by":"publisher","DOI":"10.1007\/BF00543973"},{"key":"e_1_2_1_29_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04107.x"},{"key":"e_1_2_1_30_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1992.tb04121.x"},{"key":"e_1_2_1_31_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2044.1988.tb09020.x"},{"key":"e_1_2_1_32_2","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.299.6692.150"},{"key":"e_1_2_1_33_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-199004000-00025"},{"key":"e_1_2_1_34_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(93)90188-U"},{"key":"e_1_2_1_35_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-6576.1993.tb03809.x"},{"key":"e_1_2_1_36_2","doi-asserted-by":"publisher","DOI":"10.1016\/0140-6736(92)93067-W"},{"key":"e_1_2_1_37_2","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0022-3565(25)20832-1","article-title":"Pharmacological characterization of morphine\u20136p\u2013glucuronide, a very potent morphine metabolite","volume":"251","author":"Paul D.","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_38_2","first-page":"433","article-title":"Role of \u03bc1\u2013 and \u03b4\u2013opioid receptors in modulation of fetal EEG and respiratory activity","volume":"265","author":"Cheng PY","year":"1993","journal-title":"Am J Physiol"},{"key":"e_1_2_1_39_2","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0022-3565(25)13335-1","article-title":"Respiratory and locomotor stimulation by low doses of dermorphin, a mu1 receptor\u2013mediated effect","volume":"252","author":"Paakkari P.","year":"1990","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_40_2","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0022-3565(25)10892-6","article-title":"Central opioid modulation of breathing dynamics in the fetal lamb: effects of [D\u2013Pen2, D\u2013Pen5]\u2013enkephalin and partial antagonism ny naltrindole","volume":"262","author":"Cheng PY","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_41_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90413-C"},{"key":"e_1_2_1_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(87)90431-0"},{"key":"e_1_2_1_43_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1987.tb01724.x"},{"key":"e_1_2_1_44_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(87)90710-7"},{"key":"e_1_2_1_45_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.233"},{"key":"e_1_2_1_46_2","doi-asserted-by":"crossref","unstructured":"McLoughlinL. ThompsonPI HucksD. GrossmanA. ReesL.Comparative opiate receptor subsite affinities af morphine and morphine\u20136\u2013gIucuronide.Pain1990: (suppl. 52):S187.","DOI":"10.1016\/0304-3959(90)92510-W"},{"key":"e_1_2_1_47_2","first-page":"477","article-title":"Mor\u2013phine\u20136\u2013glucuronide is more mu\u2013selective and potent in analgesic tests than morphine","volume":"328","author":"Franc\u00e9s B.","year":"1990","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_1_48_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1991.tb02056.x"},{"key":"e_1_2_1_49_2","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-3565(25)10743-X","article-title":"Further evidence that morphine\u20136\u03b2\u2013glucuronide is a more potent opioid agonist than morphine","volume":"262","author":"Frances B.","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1992.23"},{"key":"e_1_2_1_51_2","unstructured":"MignatC. WilleU.Affinity for morphine receptor subtypes is differently influenced by substitution of morphine at C3 and C6.Arch Pharmacol1994: (suppl. 349):348."},{"key":"e_1_2_1_52_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(95)00010-4"},{"key":"e_1_2_1_53_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(94)90088-4"},{"key":"e_1_2_1_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0960-894X(01)80191-8"},{"key":"e_1_2_1_55_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm00108a005"},{"key":"e_1_2_1_56_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(93)90441-J"},{"key":"e_1_2_1_57_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(92)90065-J"},{"key":"e_1_2_1_58_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(91)90199-Z"},{"key":"e_1_2_1_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(88)90479-1"},{"key":"e_1_2_1_60_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(88)91691-1"},{"key":"e_1_2_1_61_2","unstructured":"OsborneRJ.Clinical pharmacology of morphine and morphine glucuronides: the role of the active metabolite mor\u2013phine\u20136\u2013glucuronide. London:London University1988.MD Thesiss."},{"key":"e_1_2_1_62_2","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.1990.233"},{"key":"e_1_2_1_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/64.5.547"},{"key":"e_1_2_1_64_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198912000-00018"},{"key":"e_1_2_1_65_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/66.1.103"},{"key":"e_1_2_1_66_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(91)90170-3"},{"key":"e_1_2_1_67_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90201-1"},{"key":"e_1_2_1_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(94)90105-8"},{"key":"e_1_2_1_69_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1476-5381.1993.tb13802.x"},{"key":"e_1_2_1_70_2","unstructured":"ChapmanDJ.Analysis and pharmacokinetics of morphine and morphine\u20136\u2013glucuronide. Guildford:University of Surrey 1990.Ph.D Thesis."},{"key":"e_1_2_1_71_2","doi-asserted-by":"publisher","DOI":"10.1093\/bja\/70.5.511"},{"key":"e_1_2_1_72_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(90)90619-3"},{"key":"e_1_2_1_73_2","doi-asserted-by":"publisher","DOI":"10.1002\/bdd.2510140102"},{"key":"e_1_2_1_74_2","doi-asserted-by":"publisher","DOI":"10.1016\/0304-3959(93)90056-U"},{"key":"e_1_2_1_75_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)90106-6"},{"key":"e_1_2_1_76_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-198605000-00008"},{"key":"e_1_2_1_77_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(81)90176-1"},{"key":"e_1_2_1_78_2","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0022-3565(25)24481-0","article-title":"Pharmacology of the allodynia in rats evoked by high dose intrathecal morphine","volume":"244","author":"Yaksh TL","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"e_1_2_1_79_2","doi-asserted-by":"publisher","DOI":"10.1016\/0006-8993(79)90849-7"},{"key":"e_1_2_1_80_2","doi-asserted-by":"publisher","DOI":"10.1016\/0024-3205(94)00552-4"},{"key":"e_1_2_1_81_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-0773.1994.tb00327.x"}],"container-title":["Acta Anaesthesiologica Scandinavica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1399-6576.1997.tb04625.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1399-6576.1997.tb04625.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T17:42:26Z","timestamp":1738863746000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1399-6576.1997.tb04625.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1111\/j.1399-6576.1997.tb04625.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1399-6576.1997.tb04625.x","archive":["Portico"],"relation":{},"ISSN":["0001-5172","1399-6576"],"issn-type":[{"value":"0001-5172","type":"print"},{"value":"1399-6576","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}